{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:31:34Z","timestamp":1794976294536,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Self-funded scientific and technological innovation project of Foshan Science and Technology Bureau","award":["2420001003532"],"award-info":[{"award-number":["2420001003532"]}]},{"name":"the financial support of Youth program, National Natural Science Foundation of China","award":["82102183"],"award-info":[{"award-number":["82102183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14857-8","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:45:25Z","timestamp":1762249525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deciphering mismatch repair protein expression variability in gastric cancer: clinical and prognostic implications"],"prefix":"10.1186","volume":"25","author":[{"given":"Fengmei","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Like","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"14857_CR1","doi-asserted-by":"crossref","unstructured":"Wu H, Ma W, Jiang C, Li N, Xu X, Ding Y, et al. Heterogeneity and adjuvant therapeutic approaches in MSI-H\/dMMR resectable gastric cancer: emerging trends in immunotherapy. Ann Surg Oncol. 2023;30(13):8572\u201387.","DOI":"10.1245\/s10434-023-14103-0"},{"key":"14857_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","DOI":"10.3322\/caac.21834"},{"issue":"7517","key":"14857_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular characterization of gastric adenocarcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"5","key":"14857_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10120-024-01523-4","volume":"27","author":"A Ooki","year":"2024","unstructured":"Ooki A, Osumi H, Yoshino K, Yamaguchi K. Potent therapeutic strategy in gastric cancer with microsatellite instability-high and\/or deficient mismatch repair. Gastric Cancer. 2024;27(5):907\u201331.","journal-title":"Gastric Cancer"},{"key":"14857_CR5","doi-asserted-by":"crossref","unstructured":"Strickland MR, Lander EM, Gibson MK, Ilson DH, Ajani JA, Klempner SJ. Gastroesophageal adenocarcinomas with defective mismatch repair: current knowledge and clinical management. J Natl Compr Canc Netw. 2024;22(3):1\u20138.","DOI":"10.6004\/jnccn.2023.7103"},{"key":"14857_CR6","doi-asserted-by":"crossref","unstructured":"Wang Z, Cheng S, Yao Y, Liu S, Liu Z, Liu N, et al. Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR\/MSI-H colorectal and gastric cancers. Cancer Immunol Immunother. 2024;73(9):182.","DOI":"10.1007\/s00262-024-03764-9"},{"key":"14857_CR7","doi-asserted-by":"crossref","unstructured":"Gervaso L, Ciardiello D, Oliveira RA, Borghesani M, Guidi L, Benini L, et al. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe? J Immunother Cancer. 2024;12(5):e008027.","DOI":"10.1136\/jitc-2023-008027"},{"key":"14857_CR8","doi-asserted-by":"crossref","unstructured":"R\u00fcschoff J, Schildhaus HU, R\u00fcschoff JH, J\u00f6hrens K, Bocker Edmonston T, Dietmaier W, et al. Testing for deficient mismatch repair and microsatellite instability: A focused update. Pathologie (Heidelb). 2023;44(Suppl 2):61\u201370.","DOI":"10.1007\/s00292-023-01208-2"},{"key":"14857_CR9","doi-asserted-by":"crossref","unstructured":"Cohen R, Taieb J, Fiskum J, Yothers G, Goldberg R, Yoshino T, et al. Microsatellite instability in patients with stage III colon cancer receiving fluoropyrimidine with or without oxaliplatin: an ACCENT pooled analysis of 12 adjuvant trials. J Clin Oncol. 2021;39(6):642\u201351.","DOI":"10.1200\/JCO.20.01600"},{"key":"14857_CR10","doi-asserted-by":"crossref","unstructured":"Grillo F, Angerilli V, Parente P, Vanoli A, Luchini C, Sciallero S, et al. Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting. Virchows Arch. 2024;485(1):131\u20135.","DOI":"10.1007\/s00428-023-03726-z"},{"key":"14857_CR11","doi-asserted-by":"crossref","unstructured":"Berrino E, Aquilano MC, Valtorta E, Amodio V, Germano G, Gusmini M, et al. Unique patterns of heterogeneous mismatch repair protein expression in colorectal cancer unveil different degrees of tumor mutational burden and distinct tumor microenvironment features. Mod Pathol. 2023;36(2):100012.","DOI":"10.1016\/j.modpat.2022.100012"},{"key":"14857_CR12","doi-asserted-by":"crossref","unstructured":"Den\u010di\u0107 T, Petrovi\u0107 A, Jovi\u010di\u0107 Milentijevi\u0107 M, Radenkovi\u0107 G, Jovi\u0107 M, \u017divkovi\u0107 N, et al. The importance of immunohistochemical heterogeneous expression of MMR protein in patients with colorectal cancer in stage II and III of the disease. Med (Kaunas). 2023;59(3):489.","DOI":"10.3390\/medicina59030489"},{"key":"14857_CR13","doi-asserted-by":"crossref","unstructured":"Li X, Zhang S, Zeng J, Song SS, Liu X, Kang W, et al. Heterogeneous expression of mismatch repair proteins and interpretation of immunohistochemical results in colorectal cancer and endometrial cancer. Pathol Res Pract. 2023;248:154647.","DOI":"10.1016\/j.prp.2023.154647"},{"key":"14857_CR14","doi-asserted-by":"crossref","unstructured":"Scheiderer A, Riedinger C, Kimball K, Kilgore L, Orucevic A. Reporting subclonal immunohistochemical staining of mismatch repair proteins in endometrial carcinoma in the times of Ever-Changing guidelines. Arch Pathol Lab Med. 2022;146(9):1114\u201321.","DOI":"10.5858\/arpa.2021-0201-OA"},{"key":"14857_CR15","doi-asserted-by":"crossref","unstructured":"Wang J, Zhang Z, Cai Y, Lu J, Zhang H, Pang J, et al. A comprehensive study of heterogeneous mismatch repair expression in solid tumors reveals different immunohistochemical patterns and distinct genetic mechanisms. Am J Surg Pathol. 2024;48(4):417\u201325.","DOI":"10.1097\/PAS.0000000000002158"},{"key":"14857_CR16","doi-asserted-by":"crossref","unstructured":"Riedinger CJ, Esnakula A, Haight PJ, Suarez AA, Chen W, Gillespie J, et al. Characterization of mismatch-repair\/microsatellite instability-discordant endometrial cancers. Cancer. 2024;130(3):385\u201399.","DOI":"10.1002\/cncr.35030"},{"key":"14857_CR17","doi-asserted-by":"crossref","unstructured":"McCarthy AJ, Capo-Chichi JM, Spence T, Grenier S, Stockley T, Kamel-Reid S, et al. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. J Pathol Clin Res. 2019;5(2):115\u201329.","DOI":"10.1002\/cjp2.120"},{"key":"14857_CR18","doi-asserted-by":"crossref","unstructured":"Mendoza RP, Wang P, Schulte JJ, Tjota MY, Jani I, Martinez AC, et al. Endometrial carcinomas with subclonal loss of mismatch repair proteins: A clinicopathologic and genomic study. Am J Surg Pathol. 2023;47(5):589\u201398.","DOI":"10.1097\/PAS.0000000000002031"},{"key":"14857_CR19","doi-asserted-by":"crossref","unstructured":"Jaffrelot M, Far\u00e9s N, Brunac AC, Laurenty AP, Danjoux M, Grand D, et al. An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes. Mod Pathol. 2022;35(3):427\u201337.","DOI":"10.1038\/s41379-021-00918-3"},{"key":"14857_CR20","doi-asserted-by":"crossref","unstructured":"Yamamoto G, Ito T, Suzuki O, Kamae N, Kakuta M, Takahashi A, et al. Concordance between microsatellite instability testing and immunohistochemistry for mismatch repair proteins and efficient screening of mismatch repair deficient gastric cancer. Oncol Lett. 2023;26(5):494.","DOI":"10.3892\/ol.2023.14081"},{"key":"14857_CR21","doi-asserted-by":"crossref","unstructured":"Guan WL, Ma Y, Cui YH, Liu TS, Zhang YQ, Zhou ZW, et al. The impact of mismatch repair status on prognosis of patients with gastric cancer: A multicenter analysis. Front Oncol. 2021;11:712760.","DOI":"10.3389\/fonc.2021.712760"},{"key":"14857_CR22","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang X, Wang Q, Xu YY, Yao QL, Huang D, et al. Histomorphological and molecular genetic characterization of different intratumoral regions and matched metastatic lymph nodes of colorectal cancer with heterogenous mismatch repair protein expression. J Cancer Res Clin Oncol. 2023;149(7):3423\u201334.","DOI":"10.1007\/s00432-022-04261-1"},{"issue":"1","key":"14857_CR23","first-page":"948","volume":"16","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Huang J, Li Y, Yan H, Xie J, Wang J, Zhao B. Global burden, risk factors, clinicopathological characteristics, molecular biomarkers and outcomes of microsatellite instability-high gastric cancer. Aging. 2024;16(1):948\u201363.","journal-title":"Aging"},{"key":"14857_CR24","doi-asserted-by":"crossref","unstructured":"Liu B, Shen C, Yin X, Jiang T, Han Y, Yuan R, et al. Perioperative chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: A systematic review and meta-analysis. Cancer. 2025;131(7):e35831.","DOI":"10.1002\/cncr.35831"},{"issue":"1","key":"14857_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol"},{"key":"14857_CR26","doi-asserted-by":"crossref","unstructured":"Petrelli F, Antista M, Marra F, Cribiu FM, Rampulla V, Pietrantonio F, et al. Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis. Ther Adv Med Oncol. 2024;16:17588359241231259.","DOI":"10.1177\/17588359241231259"},{"issue":"21","key":"14857_CR27","doi-asserted-by":"publisher","first-page":"e29304","DOI":"10.1097\/MD.0000000000029304","volume":"101","author":"X Chang","year":"2022","unstructured":"Chang X, Ge X, Zhang Y, Xue X. The current management and biomarkers of immunotherapy in advanced gastric cancer. Med (Baltim). 2022;101(21):e29304.","journal-title":"Med (Baltim)"},{"key":"14857_CR28","doi-asserted-by":"crossref","unstructured":"Chao J, Fuchs CS, Shitara K, Tabernero J, Muro K, Van Cutsem E, et al. Assessment of pembrolizumab therapy for the treatment of microsatellite Instability-High gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials. JAMA Oncol. 2021;7(6):895\u2013902.","DOI":"10.1001\/jamaoncol.2021.0275"},{"key":"14857_CR29","doi-asserted-by":"crossref","unstructured":"Shitara K, Ajani JA, Moehler M, Garrido M, Gallardo C, Shen L, et al. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature. 2022;603(7903):942\u20138.","DOI":"10.1038\/s41586-022-04508-4"},{"key":"14857_CR30","doi-asserted-by":"crossref","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340.","DOI":"10.1016\/S0140-6736(21)00797-2"},{"key":"14857_CR31","doi-asserted-by":"crossref","unstructured":"Raimondi A, Kim YW, Kang WK, Langley RE, Choi YY, Kim KM, et al. Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: an individual patient data pooled analysis of randomized clinical trials. Eur J Cancer. 2024;203:114043.","DOI":"10.1016\/j.ejca.2024.114043"},{"key":"14857_CR32","doi-asserted-by":"crossref","unstructured":"Pietrantonio F, Miceli R, Raimondi A, Kim YW, Kang WK, Langley RE, et al. Individual patient data Meta-Analysis of the value of microsatellite instability as a biomarker in gastric cancer. J Clin Oncol. 2019;37(35):3392\u2013400.","DOI":"10.1200\/JCO.19.01124"},{"key":"14857_CR33","doi-asserted-by":"crossref","unstructured":"Nie RC, Chen GM, Yuan SQ, Kim JW, Zhou J, Nie M, et al. Adjuvant chemotherapy for gastric cancer patients with mismatch repair deficiency or microsatellite instability: systematic review and Meta-Analysis. Ann Surg Oncol. 2022;29(4):2324\u201331.","DOI":"10.1245\/s10434-021-11050-6"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14857-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:02:52Z","timestamp":1762290172000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14857-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14857"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14857-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee for Clinical Research, First Affiliated Hospital, Zhejiang University School of Medicine (Number: 20240892). Written informed consent was waived by the ethics committee. This study was conducted by the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1699"}}